

Potentially Fatal: Cardiorespiratory effects (e.g. Skin and subcutaneous tissue disorders: Rash, urticaria, pruritus. Respiratory, thoracic and mediastinal disorders: Dyspnoea, laryngospasm, bronchospasm, cough. Psychiatric disorders: Confusion, euphoric mood, depression, hallucinations, physical drug dependence, withdrawal syndrome.

Nervous system disorders: Sedation (prolonged and post-operative), decreased alertness, somnolence, headache, dizziness, drowsiness, ataxia. Musculoskeletal and connective tissue disorders: Muscle weakness. Injury, poisoning and procedural complications: Falls, fractures. General disorders and administration site conditions: Fatigue, inj site reactions (e.g. Gastrointestinal disorders: Nausea, vomiting, constipation, dry mouth, hiccups. hyperactive or aggressive behaviour), suicidal ideation, withdrawal symptoms.Ĭardiac disorders: Bradycardia, tachycardia. Significant: Anterograde amnesia, CNS depression, hypotension, paradoxical reactions (e.g.
